127 related articles for article (PubMed ID: 17084680)
21. Characterization of molecular defects in xeroderma pigmentosum group C.
Li L; Bales ES; Peterson CA; Legerski RJ
Nat Genet; 1993 Dec; 5(4):413-7. PubMed ID: 8298653
[TBL] [Abstract][Full Text] [Related]
22. A unique chromosomal in-frame deletion identified among seven XP-C patients.
Schubert S; Rieper P; Ohlenbusch A; Seebode C; Lehmann J; Gratchev A; Emmert S
Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):276-283. PubMed ID: 27387384
[TBL] [Abstract][Full Text] [Related]
23. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
[TBL] [Abstract][Full Text] [Related]
24. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
25. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells.
Dregoesc D; Rybak AP; Rainbow AJ
DNA Repair (Amst); 2007 May; 6(5):588-601. PubMed ID: 17196445
[TBL] [Abstract][Full Text] [Related]
27. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
Daya-Grosjean L; Sarasin A
Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes.
Arbault S; Sojic N; Bruce D; Amatore C; Sarasin A; Vuillaume M
Carcinogenesis; 2004 Apr; 25(4):509-15. PubMed ID: 14688028
[TBL] [Abstract][Full Text] [Related]
29. Xeroderma pigmentosum: beyond skin cancer.
Lichon V; Khachemoune A
J Drugs Dermatol; 2007 Mar; 6(3):281-8. PubMed ID: 17373189
[TBL] [Abstract][Full Text] [Related]
30. Exploring DNA damage responses in human cells with recombinant adenoviral vectors.
Armelini MG; Lima-Bessa KM; Marchetto MC; Muotri AR; Chiganças V; Leite RA; Carvalho H; Menck CF
Hum Exp Toxicol; 2007 Nov; 26(11):899-906. PubMed ID: 18042584
[TBL] [Abstract][Full Text] [Related]
31. Xeroderma pigmentosum: recent clinical and photobiological aspects.
Kondo S; Fukuro S; Nishioka K; Satoh Y
J Dermatol; 1992 Nov; 19(11):690-5. PubMed ID: 1293156
[TBL] [Abstract][Full Text] [Related]
32. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor.
Gozukara EM; Khan SG; Metin A; Emmert S; Busch DB; Shahlavi T; Coleman DM; Miller M; Chinsomboon N; Stefanini M; Kraemer KH
J Invest Dermatol; 2001 Aug; 117(2):197-204. PubMed ID: 11511294
[TBL] [Abstract][Full Text] [Related]
33. Non-radioisotope method for diagnosing photosensitive genodermatoses and a new marker for xeroderma pigmentosum variant.
Hashimoto S; Egawa K; Ihn H; Tateishi S
J Dermatol; 2009 Mar; 36(3):138-43. PubMed ID: 19335687
[TBL] [Abstract][Full Text] [Related]
34. The discovery that xeroderma pigmentosum (XP) results from defective nucleotide excision repair.
Friedberg EC
DNA Repair (Amst); 2004 Feb; 3(2):183, 195. PubMed ID: 14706352
[TBL] [Abstract][Full Text] [Related]
35. Deficient base excision repair of oxidative DNA damage induced by methylene blue plus visible light in xeroderma pigmentosum group C fibroblasts.
Kassam SN; Rainbow AJ
Biochem Biophys Res Commun; 2007 Aug; 359(4):1004-9. PubMed ID: 17573042
[TBL] [Abstract][Full Text] [Related]
36. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D).
Lai JP; Liu YC; Alimchandani M; Liu Q; Aung PP; Matsuda K; Lee CC; Tsokos M; Hewitt S; Rushing EJ; Tamura D; Levens DL; Digiovanna JJ; Fine HA; Patronas N; Khan SG; Kleiner DE; Oberholtzer JC; Quezado MM; Kraemer KH
Acta Neuropathol Commun; 2013 May; 1():4. PubMed ID: 24252196
[TBL] [Abstract][Full Text] [Related]
37. Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form.
Robbins JH; Brumback RA; Mendiones M; Barrett SF; Carl JR; Cho S; Denckla MB; Ganges MB; Gerber LH; Guthrie RA
Brain; 1991 Jun; 114 ( Pt 3)():1335-61. PubMed ID: 2065254
[TBL] [Abstract][Full Text] [Related]
38. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
[TBL] [Abstract][Full Text] [Related]
39. Assignment of three Chinese xeroderma pigmentosum patients to complementation group C and one to group E.
Han ZB; Hara R; Ayaki H; Wang JH; Sun LY; You Y; Zhang YP; Qiang KX; Ikenaga M
Br J Dermatol; 1998 Jan; 138(1):131-6. PubMed ID: 9536236
[TBL] [Abstract][Full Text] [Related]
40. Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H.
Laposa RR; Feeney L; Cleaver JE
Cancer Res; 2003 Jul; 63(14):3909-12. PubMed ID: 12873983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
